25 XP   0   0   10

Assertio Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Assertio Therapeutics Inc together

PenkeI guess you are interested in Assertio Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Assertio Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Assertio Therapeutics Inc

I send you an email if I find something interesting about Assertio Therapeutics Inc.

Quick analysis of Assertio Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Assertio Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.17
When do you have the money?
1 year
How often do you get paid?
17.5%

What is your share worth?

Current worth
$1.45
Expected worth in 1 year
$0.53
How sure are you?
45.0%

+ What do you gain per year?

Total Gains per Share
$-0.75
Return On Investment
-78.3%

For what price can you sell your share?

Current Price per Share
$0.96
Expected price per share
$0.78 - $1.28
How sure are you?
50%

1. Valuation of Assertio Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$0.96

Intrinsic Value Per Share

$4.26 - $11.02

Total Value Per Share

$5.71 - $12.47

2. Growth of Assertio Therapeutics Inc (5 min.)




Is Assertio Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$138m$150.2m$58.7m28.1%

How much money is Assertio Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$82.9m$27.4m-$110.3m-133.0%
Net Profit Margin-236.5%58.8%--

How much money comes from the company's main activities?

3. Financial Health of Assertio Therapeutics Inc (5 min.)




What can you expect buying and holding a share of Assertio Therapeutics Inc? (5 min.)

Welcome investor! Assertio Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Assertio Therapeutics Inc.

What can you expect buying and holding a share of Assertio Therapeutics Inc?

First you should know what it really means to hold a share of Assertio Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Assertio Therapeutics Inc is $0.9593. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Assertio Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Assertio Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.45. Based on the TTM, the Book Value Change Per Share is $-0.23 per quarter. Based on the YOY, the Book Value Change Per Share is $0.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Assertio Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.60-63.0%-0.84-87.8%0.2930.1%-0.24-25.1%-0.15-15.2%
Usd Book Value Change Per Share-0.58-60.2%-0.23-24.1%0.3233.8%-0.04-4.5%0.000.0%
Usd Dividend Per Share0.000.0%0.044.5%0.000.0%0.010.9%0.000.5%
Usd Total Gains Per Share-0.58-60.2%-0.19-19.6%0.3233.8%-0.03-3.6%0.000.5%
Usd Price Per Share1.07-3.86-3.10-2.34-8.09-
Price to Earnings Ratio-0.44-8.10-7.63-3.67--2.43-
Price-to-Total Gains Ratio-1.85-11.07-20.82-9.18--54.37-
Price to Book Ratio0.74-1.61-2.01-1.46-3.26-
Price-to-Total Gains Ratio-1.85-11.07-20.82-9.18--54.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9593
Number of shares1042
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.01
Usd Book Value Change Per Share-0.23-0.04
Usd Total Gains Per Share-0.19-0.03
Gains per Quarter (1042 shares)-195.78-35.83
Gains per Year (1042 shares)-783.14-143.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1179-962-79337-181-153
2358-1924-157675-361-296
3537-2887-2359112-542-439
4716-3849-3142149-722-582
5895-4811-3925186-903-725
61074-5773-4708224-1084-868
71254-6736-5491261-1264-1011
81433-7698-6274298-1445-1154
91612-8660-7057336-1626-1297
101791-9622-7840373-1806-1440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%9.03.00.075.0%11.09.00.055.0%17.023.00.042.5%30.075.00.028.6%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%12.08.00.060.0%18.022.00.045.0%45.060.00.042.9%
Dividend per Share1.00.03.025.0%2.00.010.016.7%6.00.014.030.0%7.00.033.017.5%7.00.098.06.7%
Total Gains per Share2.02.00.050.0%9.03.00.075.0%12.08.00.060.0%18.022.00.045.0%45.060.00.042.9%

Fundamentals of Assertio Therapeutics Inc

About Assertio Therapeutics Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.

Fundamental data was last updated by Penke on 2024-03-20 10:26:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Assertio Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Assertio Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Assertio Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -174.0% means that $-1.74 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Assertio Therapeutics Inc:

  • The MRQ is -174.0%. The company is making a huge loss. -2
  • The TTM is -236.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-174.0%TTM-236.5%+62.6%
TTM-236.5%YOY58.8%-295.3%
TTM-236.5%5Y-58.5%-178.0%
5Y-58.5%10Y-33.8%-24.8%
1.1.2. Return on Assets

Shows how efficient Assertio Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Assertio Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -20.0% Return on Assets means that Assertio Therapeutics Inc generated $-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Assertio Therapeutics Inc:

  • The MRQ is -20.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.0%TTM-23.1%+3.1%
TTM-23.1%YOY6.9%-30.0%
TTM-23.1%5Y-5.3%-17.7%
5Y-5.3%10Y-2.6%-2.7%
1.1.3. Return on Equity

Shows how efficient Assertio Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Assertio Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -41.6% Return on Equity means Assertio Therapeutics Inc generated $-0.42 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Assertio Therapeutics Inc:

  • The MRQ is -41.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -46.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.6%TTM-46.1%+4.6%
TTM-46.1%YOY14.1%-60.3%
TTM-46.1%5Y-26.2%-19.9%
5Y-26.2%10Y-14.3%-12.0%

1.2. Operating Efficiency of Assertio Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Assertio Therapeutics Inc is operating .

  • Measures how much profit Assertio Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Assertio Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -18.6% means the company generated $-0.19  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Assertio Therapeutics Inc:

  • The MRQ is -18.6%. The company is operating very inefficient. -2
  • The TTM is 9.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ-18.6%TTM9.4%-28.0%
TTM9.4%YOY33.9%-24.5%
TTM9.4%5Y-0.3%+9.7%
5Y-0.3%10Y3.1%-3.4%
1.2.2. Operating Ratio

Measures how efficient Assertio Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.19 means that the operating costs are $1.19 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Assertio Therapeutics Inc:

  • The MRQ is 1.186. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.916. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.186TTM0.916+0.270
TTM0.916YOY0.637+0.279
TTM0.9165Y0.996-0.081
5Y0.99610Y0.965+0.031

1.3. Liquidity of Assertio Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Assertio Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.83 means the company has $1.83 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Assertio Therapeutics Inc:

  • The MRQ is 1.831. The company is able to pay all its short-term debts. +1
  • The TTM is 1.647. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.831TTM1.647+0.184
TTM1.647YOY1.166+0.480
TTM1.6475Y1.103+0.544
5Y1.10310Y1.904-0.801
1.3.2. Quick Ratio

Measures if Assertio Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Assertio Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.30 means the company can pay off $1.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Assertio Therapeutics Inc:

  • The MRQ is 1.296. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.285. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.296TTM1.285+0.011
TTM1.285YOY1.002+0.283
TTM1.2855Y0.895+0.389
5Y0.89510Y1.573-0.678

1.4. Solvency of Assertio Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Assertio Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Assertio Therapeutics Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.52 means that Assertio Therapeutics Inc assets are financed with 51.8% credit (debt) and the remaining percentage (100% - 51.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Assertio Therapeutics Inc:

  • The MRQ is 0.518. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.445. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.518TTM0.445+0.074
TTM0.445YOY0.577-0.133
TTM0.4455Y0.644-0.199
5Y0.64410Y0.687-0.043
1.4.2. Debt to Equity Ratio

Measures if Assertio Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Assertio Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 107.5% means that company has $1.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Assertio Therapeutics Inc:

  • The MRQ is 1.075. The company is able to pay all its debts with equity. +1
  • The TTM is 0.823. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.075TTM0.823+0.252
TTM0.823YOY1.443-0.620
TTM0.8235Y2.342-1.519
5Y2.34210Y2.716-0.375

2. Market Valuation of Assertio Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Assertio Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Assertio Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.44 means the investor is paying $-0.44 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Assertio Therapeutics Inc:

  • The EOD is -0.397. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.443. Based on the earnings, the company is expensive. -2
  • The TTM is 8.099. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-0.397MRQ-0.443+0.046
MRQ-0.443TTM8.099-8.542
TTM8.099YOY7.633+0.466
TTM8.0995Y3.667+4.433
5Y3.66710Y-2.431+6.098
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Assertio Therapeutics Inc:

  • The EOD is 3.870. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.317. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 10.443. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.870MRQ4.317-0.447
MRQ4.317TTM10.443-6.127
TTM10.443YOY4.194+6.249
TTM10.4435Y5.967+4.476
5Y5.96710Y-7.342+13.310
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Assertio Therapeutics Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Assertio Therapeutics Inc:

  • The EOD is 0.660. Based on the equity, the company is cheap. +2
  • The MRQ is 0.737. Based on the equity, the company is cheap. +2
  • The TTM is 1.609. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.660MRQ0.737-0.076
MRQ0.737TTM1.609-0.873
TTM1.609YOY2.007-0.398
TTM1.6095Y1.462+0.147
5Y1.46210Y3.264-1.802
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Assertio Therapeutics Inc.

3.1. Institutions holding Assertio Therapeutics Inc

Institutions are holding 50.077% of the shares of Assertio Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Nantahala Capital Management, LLC16.09710.48771523888010568880226.3143
2023-12-31BlackRock Inc6.94470.0002657448363112210.6189
2023-12-31Armistice Capital, LLC6.12660.08475800000187600047.8084
2023-12-31Vanguard Group Inc5.15330.000148785433463887.6429
2023-12-31Renaissance Technologies Corp3.31950.0052314251458590022.917
2023-12-31Goldman Sachs Group Inc2.50930.000223755301799863312.657
2023-12-31Geode Capital Management, LLC2.11520.000220023941209806.4303
2023-12-31AQR Capital Management LLC2.10990.00419973881693034556.2713
2023-12-31State Street Corporation1.61160.0001152564915112010.9943
2023-12-31Two Sigma Investments LLC1.33230.00311261229541834.4889
2023-12-31Two Sigma Advisers, LLC1.28910.00311220415726281146.9806
2023-12-31Northern Trust Corp0.81430.0002770907301714.0731
2023-12-31Bank of New York Mellon Corp0.7060.00016683249725217.0297
2023-12-31Bridgeway Capital Management, LLC0.68680.0149650208-101885-13.5469
2023-12-31RIMA MANAGEMENT, LLC0.59460.02325628985628980
2023-12-31Morgan Stanley - Brokerage Accounts0.59330.000156164219191251.906
2023-12-31Perritt Capital Management Inc.0.39420.2234373184110003.0371
2023-12-31Empowered Funds, LLC0.37140.0094351608317659.9314
2023-12-31CM Management, LLC0.36440.2967345000177360105.7981
2023-09-30D. E. Shaw & Co LP0.31670.0008299852-254853-45.9439
Total 53.45031.157450600648+19299371+38.1%

3.2. Funds holding Assertio Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.18290.0002301316600
2024-02-29iShares Russell 2000 ETF2.42510.00332295804-375-0.0163
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.38120.0011130757000
2023-12-31Fidelity Small Cap Index0.92090.003787178300
2024-02-01iShares Russell 2000 Value ETF0.91280.00686418010940.1268
2024-01-31Fidelity Extended Market Index0.55670.001352698500
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.55580.001152620000
2024-02-29EA Bridgeway Omni Small-Cap Value ETF0.39210.02843712338200.2214
2023-10-31Goldman Sachs Small Cp Val Insghts Instl0.36950.090834982911852751.2434
2024-02-29Vanguard Russell 2000 ETF0.34440.003326054252768.4035
2023-12-31Bridgeway Omni Small-Cap Value N0.31540.0249298600-133650-30.9196
2023-12-31Bridgeway Omni Small-Cap Value0.31540.0249298600-133650-30.9196
2023-12-31Kennedy Micro Cap0.31230.0667295603-140552-32.2252
2023-12-31NT R2000 Value Index Fund - NL0.29940.008283428223218.5486
2023-12-31NT R2000 Index Fund - NL0.29730.0042281419225038.6912
2023-12-31Perritt MicroCap Opportunities Investor0.28650.531927125000
2024-02-29First Trust Dow Jones Sel MicroCap ETF0.28380.13726866400
2023-12-31NT R2000 Index Fund - DC - NL - 20.23410.0042221620169348.2732
2023-12-31BlackRock Extended Equity Market K0.22760.00172154774666427.6424
2024-01-31Schwab Small Cap Index0.21620.003220468300
Total 13.82940.945613092148-154088-1.2%

3.3. Insider Transactions

Insiders are holding 1.639% of the shares of Assertio Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-14James L TyreeSELL102511.12
2023-09-11Ajay PatelSELL643133.04
2023-09-11Daniel A PeisertSELL1272813.04
2023-09-11Paul SchwichtenbergSELL1049803.07
2023-09-11Sam SchlessingerSELL452363.04
2023-08-14William MckeeSELL220003.14
2023-05-19Heather L MasonSELL892867.3
2023-05-05James L TyreeSELL431436

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Assertio Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.578-0.231-60%0.325-278%-0.043-92%0.000-374001%
Book Value Per Share--1.4532.200-34%1.581-8%1.498-3%2.101-31%
Current Ratio--1.8311.647+11%1.166+57%1.103+66%1.904-4%
Debt To Asset Ratio--0.5180.445+17%0.577-10%0.644-19%0.687-25%
Debt To Equity Ratio--1.0750.823+31%1.443-25%2.342-54%2.716-60%
Dividend Per Share---0.043-100%0.000-100%0.009-100%0.005-100%
Eps---0.604-0.842+39%0.288-309%-0.241-60%-0.146-76%
Free Cash Flow Per Share--0.0620.129-52%0.205-70%0.082-24%0.107-42%
Free Cash Flow To Equity Per Share---0.0320.013-354%0.185-117%-0.260+715%0.104-131%
Gross Profit Margin--1.0001.0000%0.990+1%1.0020%1.038-4%
Intrinsic Value_10Y_max--11.018--------
Intrinsic Value_10Y_min--4.257--------
Intrinsic Value_1Y_max--0.558--------
Intrinsic Value_1Y_min--0.431--------
Intrinsic Value_3Y_max--2.093--------
Intrinsic Value_3Y_min--1.300--------
Intrinsic Value_5Y_max--4.129--------
Intrinsic Value_5Y_min--2.165--------
Market Cap91129470.940-12%101645506.000366208809.000-72%294249490.500-65%221904489.052-54%768726675.187-87%
Net Profit Margin---1.740-2.365+36%0.588-396%-0.585-66%-0.338-81%
Operating Margin---0.1860.094-297%0.339-155%-0.003-98%0.031-692%
Operating Ratio--1.1860.916+30%0.637+86%0.996+19%0.965+23%
Pb Ratio0.660-12%0.7371.609-54%2.007-63%1.462-50%3.264-77%
Pe Ratio-0.397+10%-0.4438.099-105%7.633-106%3.667-112%-2.431+449%
Price Per Share0.959-12%1.0703.855-72%3.098-65%2.336-54%8.092-87%
Price To Free Cash Flow Ratio3.870-12%4.31710.443-59%4.194+3%5.967-28%-7.342+270%
Price To Total Gains Ratio-1.661+10%-1.85211.070-117%20.818-109%9.178-120%-54.365+2835%
Quick Ratio--1.2961.285+1%1.002+29%0.895+45%1.573-18%
Return On Assets---0.200-0.231+15%0.069-388%-0.053-73%-0.026-87%
Return On Equity---0.416-0.461+11%0.141-394%-0.262-37%-0.143-66%
Total Gains Per Share---0.578-0.188-67%0.325-278%-0.034-94%0.005-12327%
Usd Book Value--138003000.000208952750.000-34%150217750.000-8%142318950.000-3%199625300.000-31%
Usd Book Value Change Per Share---0.578-0.231-60%0.325-278%-0.043-92%0.000-374001%
Usd Book Value Per Share--1.4532.200-34%1.581-8%1.498-3%2.101-31%
Usd Dividend Per Share---0.043-100%0.000-100%0.009-100%0.005-100%
Usd Eps---0.604-0.842+39%0.288-309%-0.241-60%-0.146-76%
Usd Free Cash Flow--5887000.00012244000.000-52%19488250.000-70%7790550.050-24%10190100.025-42%
Usd Free Cash Flow Per Share--0.0620.129-52%0.205-70%0.082-24%0.107-42%
Usd Free Cash Flow To Equity Per Share---0.0320.013-354%0.185-117%-0.260+715%0.104-131%
Usd Market Cap91129470.940-12%101645506.000366208809.000-72%294249490.500-65%221904489.052-54%768726675.187-87%
Usd Price Per Share0.959-12%1.0703.855-72%3.098-65%2.336-54%8.092-87%
Usd Profit---57384000.000-82985500.000+45%27406250.000-309%-23447050.000-59%-14180625.000-75%
Usd Revenue--32985000.00038017250.000-13%39058500.000-16%37754850.000-13%65914650.000-50%
Usd Total Gains Per Share---0.578-0.188-67%0.325-278%-0.034-94%0.005-12327%
 EOD+4 -4MRQTTM+12 -23YOY+8 -285Y+10 -2610Y+5 -31

4.2. Fundamental Score

Let's check the fundamental score of Assertio Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.397
Price to Book Ratio (EOD)Between0-10.660
Net Profit Margin (MRQ)Greater than0-1.740
Operating Margin (MRQ)Greater than0-0.186
Quick Ratio (MRQ)Greater than11.296
Current Ratio (MRQ)Greater than11.831
Debt to Asset Ratio (MRQ)Less than10.518
Debt to Equity Ratio (MRQ)Less than11.075
Return on Equity (MRQ)Greater than0.15-0.416
Return on Assets (MRQ)Greater than0.05-0.200
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Assertio Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.152
Ma 20Greater thanMa 500.992
Ma 50Greater thanMa 1000.899
Ma 100Greater thanMa 2001.035
OpenGreater thanClose1.010
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
EBITDA  29,901-8,80421,097-1,29519,802-13,2456,557-7,782-1,225



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets286,419
Total Liabilities148,416
Total Stockholder Equity138,003
 As reported
Total Liabilities 148,416
Total Stockholder Equity+ 138,003
Total Assets = 286,419

Assets

Total Assets286,419
Total Current Assets171,062
Long-term Assets115,357
Total Current Assets
Cash And Cash Equivalents 73,441
Net Receivables 47,663
Inventory 37,686
Other Current Assets 12,272
Total Current Assets  (as reported)171,062
Total Current Assets  (calculated)171,062
+/-0
Long-term Assets
Property Plant Equipment 2,039
Intangible Assets 111,332
Long-term Assets Other 1,986
Long-term Assets  (as reported)115,357
Long-term Assets  (calculated)115,357
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities93,443
Long-term Liabilities54,973
Total Stockholder Equity138,003
Total Current Liabilities
Short-term Debt 928
Accounts payable 13,439
Other Current Liabilities 79,076
Total Current Liabilities  (as reported)93,443
Total Current Liabilities  (calculated)93,443
+/-0
Long-term Liabilities
Long term Debt 38,206
Capital Lease Obligations 1,470
Long-term Liabilities Other 9,224
Long-term Liabilities  (as reported)54,973
Long-term Liabilities  (calculated)48,900
+/- 6,073
Total Stockholder Equity
Common Stock9
Retained Earnings -651,543
Other Stockholders Equity 789,537
Total Stockholder Equity (as reported)138,003
Total Stockholder Equity (calculated)138,003
+/-0
Other
Capital Stock9
Cash and Short Term Investments 73,441
Common Stock Shares Outstanding 94,669
Liabilities and Stockholders Equity 286,419
Net Debt -32,529
Net Invested Capital 176,209
Net Working Capital 77,619
Property Plant and Equipment Gross 6,670
Short Long Term Debt Total 40,912



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-31
> Total Assets 
0
0
1,500
4,600
11,500
11,000
10,400
10,300
9,100
8,200
7,100
22,435
9,126
7,485
6,195
8,733
7,055
14,487
11,420
8,747
12,723
6,749
12,587
23,179
16,394
25,575
18,610
47,693
41,072
34,844
27,565
22,869
37,166
21,847
70,393
66,378
61,547
52,615
50,362
52,617
36,984
45,805
56,230
80,645
74,060
83,599
97,006
95,084
105,484
93,907
98,487
91,581
84,213
85,328
89,481
87,031
181,339
181,261
171,785
164,372
151,959
143,109
144,916
141,653
135,228
133,980
156,744
508,653
468,705
458,480
742,436
711,065
704,424
1,322,759
1,362,592
1,363,432
1,335,632
1,246,077
1,249,686
1,225,337
1,179,724
1,085,600
1,059,507
1,038,617
1,002,071
912,195
983,507
932,866
883,464
812,874
756,866
527,170
219,274
345,724
332,797
303,274
325,424
312,016
299,305
326,547
339,135
321,976
323,344
413,913
414,274
405,179
380,028
286,419
286,419380,028405,179414,274413,913323,344321,976339,135326,547299,305312,016325,424303,274332,797345,724219,274527,170756,866812,874883,464932,866983,507912,1951,002,0711,038,6171,059,5071,085,6001,179,7241,225,3371,249,6861,246,0771,335,6321,363,4321,362,5921,322,759704,424711,065742,436458,480468,705508,653156,744133,980135,228141,653144,916143,109151,959164,372171,785181,261181,33987,03189,48185,32884,21391,58198,48793,907105,48495,08497,00683,59974,06080,64556,23045,80536,98452,61750,36252,61561,54766,37870,39321,84737,16622,86927,56534,84441,07247,69318,61025,57516,39423,17912,5876,74912,7238,74711,42014,4877,0558,7336,1957,4859,12622,4357,1008,2009,10010,30010,40011,00011,5004,6001,50000
   > Total Current Assets 
0
0
1,300
4,400
11,200
9,900
7,600
7,200
8,100
7,200
6,200
21,651
8,010
6,328
4,917
7,122
5,070
12,118
9,027
6,388
10,495
4,462
10,359
21,054
14,226
23,396
16,036
45,226
38,210
30,967
23,785
18,547
33,146
17,946
66,786
63,002
58,324
49,611
45,428
47,880
34,505
38,394
37,944
62,769
64,852
82,131
95,693
93,987
87,513
76,875
79,597
78,426
70,621
74,846
79,024
79,599
158,315
129,709
125,243
109,489
115,225
97,470
105,354
108,338
96,011
97,514
110,621
314,590
291,347
309,616
630,383
622,048
613,472
234,566
302,777
316,649
292,639
230,223
263,393
307,662
286,771
219,043
219,274
231,720
193,304
158,097
227,368
215,919
181,982
139,009
124,402
103,951
180,113
135,463
104,492
94,254
124,069
119,348
112,545
103,498
125,115
116,692
126,494
132,262
137,849
133,549
184,960
171,062
171,062184,960133,549137,849132,262126,494116,692125,115103,498112,545119,348124,06994,254104,492135,463180,113103,951124,402139,009181,982215,919227,368158,097193,304231,720219,274219,043286,771307,662263,393230,223292,639316,649302,777234,566613,472622,048630,383309,616291,347314,590110,62197,51496,011108,338105,35497,470115,225109,489125,243129,709158,31579,59979,02474,84670,62178,42679,59776,87587,51393,98795,69382,13164,85262,76937,94438,39434,50547,88045,42849,61158,32463,00266,78617,94633,14618,54723,78530,96738,21045,22616,03623,39614,22621,05410,3594,46210,4956,3889,02712,1185,0707,1224,9176,3288,01021,6516,2007,2008,1007,2007,6009,90011,2004,4001,30000
       Cash And Cash Equivalents 
0
0
200
4,100
11,000
8,700
6,300
4,100
2,500
3,000
2,000
934
4,424
2,621
2,977
3,878
4,572
7,389
4,607
5,150
9,693
3,213
9,074
11,533
1,628
9,373
2,982
20,045
12,492
1,974
1,264
953
10,325
1,062
20,959
7,566
8,195
4,895
2,748
14,574
5,165
9,554
9,584
14,374
11,592
48,934
14,120
22,127
9,588
8,153
17,650
26,821
7,424
22,245
20,225
22,526
83,850
36,311
19,945
24,043
40,211
13,521
27,372
77,892
21,930
44,934
64,282
276,017
213,065
211,145
559,612
566,402
52,783
122,559
107,500
209,768
181,973
87,821
137,093
177,420
187,810
113,225
107,585
128,089
101,693
57,233
121,904
110,949
109,691
68,348
54,181
42,107
105,973
59,403
34,737
20,786
61,033
54,428
58,726
36,810
61,389
52,264
64,826
64,941
68,603
70,175
76,888
73,441
73,44176,88870,17568,60364,94164,82652,26461,38936,81058,72654,42861,03320,78634,73759,403105,97342,10754,18168,348109,691110,949121,90457,233101,693128,089107,585113,225187,810177,420137,09387,821181,973209,768107,500122,55952,783566,402559,612211,145213,065276,01764,28244,93421,93077,89227,37213,52140,21124,04319,94536,31183,85022,52620,22522,2457,42426,82117,6508,1539,58822,12714,12048,93411,59214,3749,5849,5545,16514,5742,7484,8958,1957,56620,9591,06210,3259531,2641,97412,49220,0452,9829,3731,62811,5339,0743,2139,6935,1504,6077,3894,5723,8782,9772,6214,4249342,0003,0002,5004,1006,3008,70011,0004,10020000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
4,100
4,000
3,532
3,021
2,999
1,501
2,621
0
3,829
3,012
0
0
0
0
8,685
11,418
13,061
12,152
24,211
24,782
28,128
22,037
17,152
22,147
15,884
43,882
51,508
46,468
40,447
30,863
16,985
20,606
20,711
20,033
39,091
44,494
22,266
71,332
59,932
67,554
59,659
53,338
42,922
51,527
45,097
46,609
47,825
51,895
77,522
89,018
62,106
52,726
58,691
52,537
37,737
44,423
24,618
16,294
27,263
13,202
6,893
6,774
70,773
8,310
23,906
64,984
108,684
10,351
29,925
45,554
59,711
6,702
3,574
5,872
1,205
0
0
0
0
0
7,114
0
0
0
0
0
1,579
1,579
0
0
0
0
0
0
0
0
0
0
0
000000000001,5791,579000007,114000001,2055,8723,5746,70259,71145,55429,92510,351108,68464,98423,9068,31070,7736,7746,89313,20227,26316,29424,61844,42337,73752,53758,69152,72662,10689,01877,52251,89547,82546,60945,09751,52742,92253,33859,65967,55459,93271,33222,26644,49439,09120,03320,71120,60616,98530,86340,44746,46851,50843,88215,88422,14717,15222,03728,12824,78224,21112,15213,06111,4188,68500003,0123,82902,6211,5012,9993,0213,5324,0004,100000000000
       Net Receivables 
0
0
200
100
100
100
200
300
200
0
0
17,015
376
586
360
454
387
766
1,280
1,040
647
1,151
1,241
302
660
340
600
278
179
120
28
0
0
410
776
1,956
1,730
774
6,804
9,082
1,082
1,733
3,056
3,623
2,928
3,887
4,122
3,675
3,998
4,718
5,483
4,933
6,276
4,461
9,270
6,347
16,778
7,944
7,472
12,555
10,622
10,888
14,902
13,692
15,307
14,783
16,081
22,275
47,665
55,282
49,356
32,108
27,926
74,388
88,877
78,045
77,112
86,336
101,894
102,589
67,813
78,708
77,698
72,482
62,428
42,149
43,912
37,211
43,488
34,311
43,427
42,744
62,971
34,753
39,223
44,350
39,241
45,468
36,145
44,361
48,923
48,537
44,680
45,357
46,466
41,608
62,467
47,663
47,66362,46741,60846,46645,35744,68048,53748,92344,36136,14545,46839,24144,35039,22334,75362,97142,74443,42734,31143,48837,21143,91242,14962,42872,48277,69878,70867,813102,589101,89486,33677,11278,04588,87774,38827,92632,10849,35655,28247,66522,27516,08114,78315,30713,69214,90210,88810,62212,5557,4727,94416,7786,3479,2704,4616,2764,9335,4834,7183,9983,6754,1223,8872,9283,6233,0561,7331,0829,0826,8047741,7301,95677641000281201792786003406603021,2411,1516471,0401,28076638745436058637617,0150020030020010010010020000
       Other Current Assets 
0
0
900
200
100
1,100
1,100
2,800
5,400
100
200
169
189
122
80
169
111
133
128
198
154
99
44
534
519
622
303
692
758
745
456
442
674
485
547
1,108
1,217
2,273
2,633
2,756
3,261
2,003
1,420
2,418
3,632
3,497
3,111
5,404
3,471
1,979
972
1,185
2,634
1,567
1,958
1,330
2,327
2,918
5,516
5,390
5,112
6,341
2,748
7,167
5,608
5,953
6,142
6,153
22,123
7,046
14,123
15,082
8,397
27,243
20,461
18,342
12,349
15,705
13,148
14,620
12,487
13,103
17,704
18,107
23,815
53,738
57,297
64,363
25,726
26,231
23,480
15,688
10,651
15,909
17,063
17,406
14,865
12,835
12,193
14,838
5,323
3,632
2,720
8,268
6,554
2,949
2,895
12,272
12,2722,8952,9496,5548,2682,7203,6325,32314,83812,19312,83514,86517,40617,06315,90910,65115,68823,48026,23125,72664,36357,29753,73823,81518,10717,70413,10312,48714,62013,14815,70512,34918,34220,46127,2438,39715,08214,1237,04622,1236,1536,1425,9535,6087,1672,7486,3415,1125,3905,5162,9182,3271,3301,9581,5672,6341,1859721,9793,4715,4043,1113,4973,6322,4181,4202,0033,2612,7562,6332,2731,2171,1085474856744424567457586923036225195344499154198128133111169801221891692001005,4002,8001,1001,10010020090000
   > Long-term Assets 
0
0
200
200
300
1,100
2,800
3,100
1,000
1,000
900
784
1,116
1,157
1,278
1,611
1,985
2,369
2,392
2,359
2,229
2,287
2,228
2,125
2,168
2,179
2,574
2,467
2,861
3,877
3,780
4,321
4,020
3,901
3,607
3,376
3,223
3,004
4,934
4,737
2,479
7,411
18,286
17,876
9,208
1,468
1,313
1,097
17,971
17,032
18,890
13,155
13,592
10,482
10,457
7,432
23,024
51,552
46,542
54,883
36,734
45,639
39,562
33,315
39,217
36,466
46,123
194,063
177,358
148,864
112,053
89,017
90,952
1,088,193
1,059,815
1,046,783
1,042,993
1,015,854
986,293
917,675
892,953
866,557
840,233
806,897
808,767
754,098
756,139
716,947
701,482
673,865
632,464
423,219
39,161
210,261
228,305
209,020
201,355
192,668
186,760
223,049
214,020
205,284
196,850
281,651
276,425
271,630
195,068
115,357
115,357195,068271,630276,425281,651196,850205,284214,020223,049186,760192,668201,355209,020228,305210,26139,161423,219632,464673,865701,482716,947756,139754,098808,767806,897840,233866,557892,953917,675986,2931,015,8541,042,9931,046,7831,059,8151,088,19390,95289,017112,053148,864177,358194,06346,12336,46639,21733,31539,56245,63936,73454,88346,54251,55223,0247,43210,45710,48213,59213,15518,89017,03217,9711,0971,3131,4689,20817,87618,2867,4112,4794,7374,9343,0043,2233,3763,6073,9014,0204,3213,7803,8772,8612,4672,5742,1792,1682,1252,2282,2872,2292,3592,3922,3691,9851,6111,2781,1571,1167849001,0001,0003,1002,8001,10030020020000
       Property Plant Equipment 
0
0
200
200
300
500
800
1,000
1,000
900
800
780
821
863
985
1,317
1,691
2,075
2,098
2,065
1,937
1,995
1,936
1,833
1,825
1,853
2,042
2,141
2,412
3,342
3,454
3,941
3,694
3,668
3,378
3,147
2,995
2,823
2,738
2,541
2,282
2,108
1,860
1,621
1,413
1,271
1,116
900
777
666
1,033
942
871
741
686
698
782
994
1,140
1,070
1,099
1,400
5,250
8,237
8,090
8,169
8,382
8,340
8,142
7,731
7,357
7,055
7,170
16,013
15,417
14,794
15,075
16,194
16,065
15,526
15,107
14,532
13,943
13,024
11,658
11,113
11,808
13,064
16,625
13,050
3,873
3,497
3,233
7,349
3,773
2,437
2,172
1,915
1,678
1,527
1,915
1,133
1,197
744
544
877
804
2,039
2,0398048775447441,1971,1331,9151,5271,6781,9152,1722,4373,7737,3493,2333,4973,87313,05016,62513,06411,80811,11311,65813,02413,94314,53215,10715,52616,06516,19415,07514,79415,41716,0137,1707,0557,3577,7318,1428,3408,3828,1698,0908,2375,2501,4001,0991,0701,1409947826986867418719421,0336667779001,1161,2711,4131,6211,8602,1082,2822,5412,7382,8232,9953,1473,3783,6683,6943,9413,4543,3422,4122,1412,0421,8531,8251,8331,9361,9951,9372,0652,0982,0751,6911,3179858638217808009001,0001,00080050030020020000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,147
9,008
0
0
0
0
0
0
0
0
0
0
0
19,856
0
019,856000000000009,00814,147000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,377
45,233
53,644
35,634
16,819
7,749
11,079
6,536
4,669
4,786
4,080
4,577
5,661
6,140
6,961
6,641
4,559
2,027
0
2,010
1,184
1,182
0
0
0
0
0
0
0
0
11,784
10,362
8,589
7,244
13,064
8,132
1,579
0
1,579
0
0
0
1,579
1,579
1,579
1,579
268
0
0
0
0
00002681,5791,5791,5791,5790001,57901,5798,13213,0647,2448,58910,36211,784000000001,1821,1842,01002,0274,5596,6416,9616,1405,6614,5774,0804,7864,6696,53611,0797,74916,81935,63453,64445,23350,377000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,995
26,037
25,078
24,267
23,304
32,626
82,520
79,982
77,440
74,901
72,361
69,822
1,062,579
1,035,566
1,008,994
981,957
954,920
927,884
902,149
876,414
850,679
824,944
793,873
768,429
742,985
717,542
692,099
666,655
641,212
615,768
400,535
23,671
179,716
206,628
200,082
193,536
186,318
179,143
216,054
207,554
199,585
191,617
197,996
191,712
185,428
170,413
111,332
111,332170,413185,428191,712197,996191,617199,585207,554216,054179,143186,318193,536200,082206,628179,71623,671400,535615,768641,212666,655692,099717,542742,985768,429793,873824,944850,679876,414902,149927,884954,920981,9571,008,9941,035,5661,062,57969,82272,36174,90177,44079,98282,52032,62623,30424,26725,07826,03726,9950000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
295
294
294
294
294
294
294
294
292
292
292
292
343
326
532
326
450
535
326
380
326
233
229
229
229
181
2,196
2,196
197
5,303
16,426
16,255
7,795
197
197
197
17,194
16,366
17,857
12,213
12,721
9,741
9,771
6,734
22,242
50,558
45,402
53,813
35,635
44,239
34,312
38,149
31,127
28,297
37,741
163,268
147,258
141,133
102,629
86,390
83,782
1,074,583
1,044,398
1,039,666
1,027,918
999,660
972,674
903,607
877,846
852,025
826,290
794,742
28,680
30,997
26,789
7,812
2,994
7,788
2,580
3,347
4,125
7,470
8,896
206,583
2,293
4,435
5,939
5,468
2,972
4,566
4,298
82,506
0
83,996
0
0
0083,996082,5064,2984,5662,9725,4685,9394,4352,293206,5838,8967,4704,1253,3472,5807,7882,9947,81226,78930,99728,680794,742826,290852,025877,846903,607972,674999,6601,027,9181,039,6661,044,3981,074,58383,78286,390102,629141,133147,258163,26837,74128,29731,12738,14934,31244,23935,63553,81345,40250,55822,2426,7349,7719,74112,72112,21317,85716,36617,1941971971977,79516,25516,4265,3031972,1962,196181229229229233326380326535450326532326343292292292292294294294294294294294295000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,342
62,374
57,705
14,264
0
0
0
0
22,995
42,584
42,189
42,344
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000042,34442,18942,58422,995000014,26457,70562,37476,3420000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
2,300
500
300
400
300
1,100
800
1,000
1,300
13,216
1,558
2,023
2,986
4,146
5,521
6,501
8,035
10,224
11,365
24,478
26,921
29,593
29,126
26,732
13,906
13,116
12,974
14,304
13,577
14,465
14,296
5,471
60,545
59,617
60,311
59,917
69,474
79,906
74,464
70,972
36,566
35,125
35,162
40,480
53,610
61,931
81,831
79,002
80,376
75,855
71,452
67,598
69,054
63,925
56,366
55,442
53,538
58,454
52,924
57,708
59,268
57,717
54,972
51,049
64,531
371,237
308,356
279,154
478,967
346,618
344,356
976,661
1,020,937
1,048,377
1,035,893
948,975
958,955
974,549
949,509
874,204
860,860
869,109
795,981
720,989
741,098
712,531
674,919
615,435
508,432
469,212
135,237
260,746
256,847
247,760
220,121
219,751
202,445
224,133
227,273
193,607
188,429
188,188
163,610
150,908
187,155
148,416
148,416187,155150,908163,610188,188188,429193,607227,273224,133202,445219,751220,121247,760256,847260,746135,237469,212508,432615,435674,919712,531741,098720,989795,981869,109860,860874,204949,509974,549958,955948,9751,035,8931,048,3771,020,937976,661344,356346,618478,967279,154308,356371,23764,53151,04954,97257,71759,26857,70852,92458,45453,53855,44256,36663,92569,05467,59871,45275,85580,37679,00281,83161,93153,61040,48035,16235,12536,56670,97274,46479,90669,47459,91760,31159,61760,5455,47114,29614,46513,57714,30412,97413,11613,90626,73229,12629,59326,92124,47811,36510,2248,0356,5015,5214,1462,9862,0231,55813,2161,3001,0008001,1003004003005002,30000
   > Total Current Liabilities 
0
0
2,300
400
200
200
300
600
400
500
800
12,806
1,189
1,697
1,712
2,377
2,569
3,119
3,418
4,657
4,932
5,992
8,405
8,574
8,028
5,507
4,554
3,619
3,333
4,464
3,011
3,474
13,627
4,844
32,004
8,071
9,682
10,204
20,632
22,339
18,712
16,293
15,398
14,334
14,708
17,220
16,137
22,378
26,931
27,713
32,740
32,202
31,489
31,358
35,625
32,984
32,412
32,114
34,218
39,840
35,702
40,274
42,888
51,367
32,065
28,047
34,119
119,228
282,926
114,605
58,817
52,686
61,720
133,179
180,221
196,794
309,121
217,851
210,817
221,772
301,531
278,941
263,150
224,402
257,128
125,032
261,074
124,903
222,962
176,938
205,732
184,553
122,293
134,372
131,374
132,686
109,090
116,914
100,480
135,019
138,527
116,150
92,296
95,316
94,545
79,478
114,289
93,443
93,443114,28979,47894,54595,31692,296116,150138,527135,019100,480116,914109,090132,686131,374134,372122,293184,553205,732176,938222,962124,903261,074125,032257,128224,402263,150278,941301,531221,772210,817217,851309,121196,794180,221133,17961,72052,68658,817114,605282,926119,22834,11928,04732,06551,36742,88840,27435,70239,84034,21832,11432,41232,98435,62531,35831,48932,20232,74027,71326,93122,37816,13717,22014,70814,33415,39816,29318,71222,33920,63210,2049,6828,07132,0044,84413,6273,4743,0114,4643,3333,6194,5545,5078,0288,5748,4055,9924,9324,6573,4183,1192,5692,3771,7121,6971,18912,8068005004006003002002004002,30000
       Short-term Debt 
0
0
1,400
0
100
100
100
200
100
200
100
164
165
165
171
179
156
330
471
556
534
528
501
436
441
405
359
316
273
215
162
105
10,533
6
3,051
2,771
2,927
2,621
6,454
7,972
5,626
5,752
8,113
5,202
4,770
587
2,621
3,356
3,423
3,528
3,636
3,747
3,859
3,978
3,149
2,170
1,160
121
22,408
24,367
21,029
27,311
29,383
29,388
23,811
23,491
27,744
44,474
1,645
41,904
-67,339
229,891
0
798,831
57,451
563,473
100,000
61,987
465,453
466,051
100,000
57,500
57,500
82,500
107,500
105,000
125,000
120,000
115,000
80,000
80,000
80,000
57,866
7,374
11,010
11,942
12,338
12,222
12,257
12,174
12,271
11,662
2,175
470
470
229
970
928
9289702294704702,17511,66212,27112,17412,25712,22212,33811,94211,0107,37457,86680,00080,00080,000115,000120,000125,000105,000107,50082,50057,50057,500100,000466,051465,45361,987100,000563,47357,451798,8310229,891-67,33941,9041,64544,47427,74423,49123,81129,38829,38327,31121,02924,36722,4081211,1602,1703,1493,9783,8593,7473,6363,5283,4233,3562,6215874,7705,2028,1135,7525,6267,9726,4542,6212,9272,7713,051610,53310516221527331635940544143650152853455647133015617917116516516410020010020010010010001,40000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
229,891
0
0
0
800,325
0
0
0
718,776
0
0
57,500
82,500
107,500
105,000
125,000
120,000
115,000
80,000
80,000
80,000
57,866
7,374
11,010
11,942
12,338
12,222
12,257
12,174
12,271
11,662
2,175
470
470
0
0
0
0004704702,17511,66212,27112,17412,25712,22212,33811,94211,0107,37457,86680,00080,00080,000115,000120,000125,000105,000107,50082,50057,50000718,776000800,325000229,89100000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
600
300
100
100
100
200
100
100
400
220
394
327
631
798
1,323
1,566
1,428
2,327
2,636
2,276
3,718
4,804
5,554
3,501
3,049
2,024
1,706
2,472
1,410
1,733
1,557
2,773
1,742
1,589
2,106
3,092
4,107
4,886
4,568
2,561
1,040
1,134
1,046
722
1,345
559
874
865
2,853
709
638
587
1,131
18,473
464
2,246
3,380
2,417
3,782
2,857
2,857
2,360
4,115
866
2,544
9,134
39,474
2,370
45,582
52,686
2,439
133,179
14,062
196,794
22,584
33,041
18,471
14,855
7,176
12,407
7,033
14,732
10,203
3,144
17,394
6,138
5,421
2,188
22,700
16,193
4,982
28,535
22,981
14,808
10,609
16,483
7,666
6,685
8,523
9,415
8,374
5,991
6,173
11,182
19,004
13,439
13,43919,00411,1826,1735,9918,3749,4158,5236,6857,66616,48310,60914,80822,98128,5354,98216,19322,7002,1885,4216,13817,3943,14410,20314,7327,03312,4077,17614,85518,47133,04122,584196,79414,062133,1792,43952,68645,5822,37039,4749,1342,5448664,1152,3602,8572,8573,7822,4173,3802,24646418,4731,1315876387092,8538658745591,3457221,0461,1341,0402,5614,5684,8864,1073,0922,1061,5891,7422,7731,5571,7331,4102,4721,7062,0243,0493,5015,5544,8043,7182,2762,6362,3271,4281,5661,32379863132739422040010010020010010010030060000
       Other Current Liabilities 
0
0
300
100
0
0
100
200
200
200
300
12,422
630
1,205
910
1,401
1,090
848
876
984
888
2,031
2,425
305
173
39
1,147
1,278
1,354
1,777
1,365
1,560
1,461
1,991
93
139
876
719
675
4,881
4,080
3,542
4,791
6,545
7,439
14,431
9,642
14,101
10,305
11,018
13,963
14,927
14,239
14,080
15,546
635
18,767
21,680
387
64
53
37
332
830
1,098
649
649
50,104
227,051
67,290
67,339
56,221
59,281
3,580
3,595
-684,531
64,504
5,016
-397,779
-390,670
65,790
2,768
2,684
-8,658
2,427
1,746
1,432
1,133
2,116
2,100
2,096
2,094
2,066
11,705
9,560
9,458
12,037
18,491
18,752
48,799
117,733
95,073
81,747
88,855
87,902
68,296
95,285
79,076
79,07695,28568,29687,90288,85581,74795,073117,73348,79918,75218,49112,0379,4589,56011,7052,0662,0942,0962,1002,1161,1331,4321,7462,427-8,6582,6842,76865,790-390,670-397,7795,01664,504-684,5313,5953,58059,28156,22167,33967,290227,05150,1046496491,09883033237536438721,68018,76763515,54614,08014,23914,92713,96311,01810,30514,1019,64214,4317,4396,5454,7913,5424,0804,881675719876139931,9911,4611,5601,3651,7771,3541,2781,147391733052,4252,0318889848768481,0901,4019101,20563012,4223002002002001000010030000
   > Long-term Liabilities 
0
0
0
100
100
200
100
500
400
500
500
411
369
325
1,274
1,769
2,952
3,383
4,617
5,567
6,433
18,486
18,515
21,019
21,098
21,225
9,351
9,498
9,641
9,840
10,566
10,992
669
627
28,541
51,545
50,629
49,712
48,842
57,567
55,752
54,679
21,168
20,791
20,454
23,260
37,473
39,553
54,900
51,289
47,636
43,653
39,963
36,240
33,429
30,941
23,954
23,328
19,320
18,614
17,222
17,434
16,380
6,350
22,907
23,002
30,412
252,009
25,430
164,549
420,150
293,932
282,636
843,482
840,716
851,583
726,772
731,124
748,138
752,777
647,978
595,263
597,710
644,707
538,853
595,957
480,024
587,628
451,957
438,497
302,700
284,659
12,944
126,374
125,473
115,074
111,031
102,837
101,965
89,114
88,746
77,457
96,133
92,872
69,065
71,430
72,866
54,973
54,97372,86671,43069,06592,87296,13377,45788,74689,114101,965102,837111,031115,074125,473126,37412,944284,659302,700438,497451,957587,628480,024595,957538,853644,707597,710595,263647,978752,777748,138731,124726,772851,583840,716843,482282,636293,932420,150164,54925,430252,00930,41223,00222,9076,35016,38017,43417,22218,61419,32023,32823,95430,94133,42936,24039,96343,65347,63651,28954,90039,55337,47323,26020,45420,79121,16854,67955,75257,56748,84249,71250,62951,54528,54162766910,99210,5669,8409,6419,4989,35121,22521,09821,01918,51518,4866,4335,5674,6173,3832,9521,7691,274325369411500500400500100200100100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
226,772
229,891
233,057
798,831
802,609
806,508
704,562
709,728
714,188
718,776
623,427
572,050
576,889
544,230
524,647
475,038
460,527
446,107
429,022
415,077
285,584
271,258
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000271,258285,584415,077429,022446,107460,527475,038524,647544,230576,889572,050623,427718,776714,188709,728704,562806,508802,609798,831233,057229,891226,7720000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,342
62,374
57,705
14,264
0
0
0
0
22,995
42,584
42,189
42,344
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000042,34442,18942,58422,995000014,26457,70562,37476,3420000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
711
474
628
28,542
51,546
50,629
49,713
48,842
57,566
55,752
54,679
21,168
20,791
20,454
20,335
30,974
33,778
49,880
47,190
44,487
41,483
38,803
36,119
33,429
30,941
23,954
23,328
19,320
18,614
17,222
17,434
16,380
21,036
22,907
23,002
30,412
214,380
189,474
164,549
136,233
26,639
23,655
23,175
22,767
22,237
22,210
21,396
28,737
28,531
24,551
23,213
20,821
14,299
14,206
14,173
19,497
20,388
16,578
17,560
11,775
8,581
12,944
34,540
48,238
40,099
37,025
36,086
35,555
27,795
27,193
27,957
30,151
26,469
0
31,928
0
0
0031,928026,46930,15127,95727,19327,79535,55536,08637,02540,09948,23834,54012,9448,58111,77517,56016,57820,38819,49714,17314,20614,29920,82123,21324,55128,53128,73721,39622,21022,23722,76723,17523,65526,639136,233164,549189,474214,38030,41223,00222,90721,03616,38017,43417,22218,61419,32023,32823,95430,94133,42936,11938,80341,48344,48747,19049,88033,77830,97420,33520,45420,79121,16854,67955,75257,56648,84249,71350,62951,54628,5426284747110000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,328
19,320
17,932
16,545
15,158
13,770
15,516
14,756
13,995
13,235
12,475
11,715
10,954
10,194
32,589
25,924
18,994
15,340
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000015,34018,99425,92432,58910,19410,95411,71512,47513,23513,99514,75615,51613,77015,15816,54517,93219,32023,328000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
-800
4,100
11,200
10,600
10,100
9,200
8,300
7,200
5,800
9,218
7,568
5,462
3,209
4,586
1,534
7,985
3,385
-1,477
1,358
-17,730
-14,334
-6,414
-12,732
-1,156
4,704
34,576
28,098
20,540
13,988
8,403
22,871
16,375
9,847
6,761
1,237
-7,302
-19,112
-27,288
-37,480
-25,167
19,664
45,520
38,898
43,119
43,396
33,153
23,653
14,905
18,111
15,726
12,761
17,730
20,427
23,106
124,973
125,819
118,247
105,918
99,035
85,401
85,648
83,936
80,256
82,931
92,213
137,416
160,349
179,326
263,469
364,447
360,068
346,098
341,655
315,055
299,739
297,102
290,731
250,788
230,215
211,396
198,647
169,508
206,090
191,206
242,409
220,335
208,545
197,439
248,434
57,958
84,037
84,978
75,950
55,514
105,303
92,265
96,860
102,414
111,862
128,369
134,915
225,725
250,664
254,271
192,873
138,003
138,003192,873254,271250,664225,725134,915128,369111,862102,41496,86092,265105,30355,51475,95084,97884,03757,958248,434197,439208,545220,335242,409191,206206,090169,508198,647211,396230,215250,788290,731297,102299,739315,055341,655346,098360,068364,447263,469179,326160,349137,41692,21382,93180,25683,93685,64885,40199,035105,918118,247125,819124,97323,10620,42717,73012,76115,72618,11114,90523,65333,15343,39643,11938,89845,52019,664-25,167-37,480-27,288-19,112-7,3021,2376,7619,84716,37522,8718,40313,98820,54028,09834,5764,704-1,156-12,732-6,414-14,334-17,7301,358-1,4773,3857,9851,5344,5863,2095,4627,5689,2185,8007,2008,3009,20010,10010,60011,2004,100-80000
   Common Stock
0
0
0
0
0
0
0
0
0
14,800
14,800
14,797
19,725
19,731
19,781
24,601
24,713
36,100
36,081
36,109
44,499
44,426
56,665
56,679
56,653
76,390
77,221
116,541
116,751
116,862
116,876
117,071
138,274
138,491
138,857
139,641
141,532
142,954
143,662
144,821
145,482
166,767
167,184
168,287
168,912
169,726
170,527
183,196
183,917
184,747
186,526
187,895
188,756
189,556
190,342
191,343
194,404
200,831
202,022
203,511
205,339
207,492
209,217
211,266
213,085
215,317
218,070
221,124
225,363
230,858
234,872
239,961
246,034
252,635
258,208
264,511
269,864
277,912
283,899
291,634
298,055
306,103
309,351
313,857
316,727
323,045
6
6
6
6
8
8
8
11
12
13
18
4
4
4
4
5
5
5
5
5
9
9
99555554444181312118886666323,045316,727313,857309,351306,103298,055291,634283,899277,912269,864264,511258,208252,635246,034239,961234,872230,858225,363221,124218,070215,317213,085211,266209,217207,492205,339203,511202,022200,831194,404191,343190,342189,556188,756187,895186,526184,747183,917183,196170,527169,726168,912168,287167,184166,767145,482144,821143,662142,954141,532139,641138,857138,491138,274117,071116,876116,862116,751116,54177,22176,39056,65356,67956,66544,42644,49936,10936,08136,10024,71324,60119,78119,73119,72514,79714,80014,800000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-75,167
-83,743
-97,580
-106,384
-122,162
-123,657
-127,361
-132,841
-132,363
-125,849
-84,048
-66,109
-53,364
-46,909
47,714
36,081
14,428
2,644
-28,024
-48,941
-59,482
-72,376
-116,744
-143,753
-170,412
-186,404
-219,508
-185,684
-206,732
-158,462
-182,600
-196,901
-210,506
-207,175
-399,801
-358,571
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000-358,571-399,801-207,175-210,506-196,901-182,600-158,462-206,732-185,684-219,508-186,404-170,412-143,753-116,744-72,376-59,482-48,941-28,0242,64414,42836,08147,714-46,909-53,364-66,109-84,048-125,849-132,363-132,841-127,361-123,657-122,162-106,384-97,580-83,743-75,167000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
-400
0
16,720
-226
-159
-83
-28
-3
-4
3
0
0
0
0
3
13
-981
-929
-869
-876
-915
-778
-698
-658
-559
-486
-443
-106
-149
-34
-13
-1
-12
83
110
144
71
-181
151
85
122
176
33
34
80
99
69
58
155
-32
-13
80
71
88
31
12
-23
-8
-7
-17
-18
-32
-37
-15
-32
-17
-54
-18
-19
-31
-19
-4
-2
-7
-5
-3
-4
-4
-5
-5
-5
-11,667
-11,870
0
-10,693
-10,570
0
-11,050
0
0
0
0
0
0
0
0
0
0
0
00000000000-11,0500-10,570-10,6930-11,870-11,667-5-5-5-4-4-3-5-7-2-4-19-31-19-18-54-17-32-15-37-32-18-17-7-8-231231887180-13-3215558699980343317612285151-1817114411083-12-1-13-34-149-106-443-486-559-658-698-778-915-876-869-929-98113300003-4-3-28-83-159-22616,7200-400000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
347
1,112
1,850
75,538
76,809
77,968
79,067
80,820
78,622
78,834
78,691
79,239
75,917
75,917
75,707
75,707
75,164
75,050
74,897
400,869
402,934
405,445
407,944
455,601
457,751
442,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000442,600457,751455,601407,944405,445402,934400,86974,89775,05075,16475,70775,70775,91775,91779,23978,69178,83478,62280,82079,06777,96876,80975,5381,8501,1123470000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
100
6,400
14,000
14,000
14,100
14,300
14,400
100
-300
0
0
0
0
0
0
0
0
0
0
44,426
0
0
0
0
0
0
0
0
0
0
0
0
0
0
141,532
0
143,663
144,821
145,483
166,767
167,184
168,287
168,912
169,726
170,527
-117,192
0
0
0
187,895
188,756
189,556
190,342
191,343
194,404
200,831
-32
203,511
205,339
207,492
209,217
31
12
-23
-8
347
1,112
1,850
75,538
76,809
77,968
79,067
80,820
78,622
78,834
78,691
79,239
75,917
75,917
75,707
75,707
75,164
75,050
74,897
400,869
402,934
405,445
407,944
455,601
457,751
442,600
488,730
490,100
483,446
539,736
529,831
530,689
531,636
532,020
540,692
543,064
545,321
573,744
568,881
787,023
789,537
789,537787,023568,881573,744545,321543,064540,692532,020531,636530,689529,831539,736483,446490,100488,730442,600457,751455,601407,944405,445402,934400,86974,89775,05075,16475,70775,70775,91775,91779,23978,69178,83478,62280,82079,06777,96876,80975,5381,8501,112347-8-231231209,217207,492205,339203,511-32200,831194,404191,343190,342189,556188,756187,895000-117,192170,527169,726168,912168,287167,184166,767145,483144,821143,6630141,5320000000000000044,4260000000000-30010014,40014,30014,10014,00014,0006,40010000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue152,069
Cost of Revenue-55,247
Gross Profit96,82296,822
 
Operating Income (+$)
Gross Profit96,822
Operating Expense-71,881
Operating Income24,94124,941
 
Operating Expense (+$)
Research Development2,843
Selling General Administrative78,638
Selling And Marketing Expenses0
Operating Expense71,88181,481
 
Net Interest Income (+$)
Interest Income0
Interest Expense-3,380
Other Finance Cost-9,918
Net Interest Income-13,298
 
Pretax Income (+$)
Operating Income24,941
Net Interest Income-13,298
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-254,054303,936
EBIT - interestExpense = 21,561
-254,054
-328,562
Interest Expense3,380
Earnings Before Interest and Taxes (EBIT)24,941-250,674
Earnings Before Interest and Taxes (EBITDA)53,168
 
After tax Income (+$)
Income Before Tax-254,054
Tax Provision-77,888
Net Income From Continuing Ops-331,942-331,942
Net Income-331,942
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses127,128
Total Other Income/Expenses Net-278,99513,298
 

Technical Analysis of Assertio Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Assertio Therapeutics Inc. The general trend of Assertio Therapeutics Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Assertio Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Assertio Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.96 < 1.21 < 1.28.

The bearish price targets are: 0.9487 > 0.78 > 0.78.

Tweet this
Assertio Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Assertio Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Assertio Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Assertio Therapeutics Inc. The current macd is 0.0318149.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Assertio Therapeutics Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Assertio Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Assertio Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Assertio Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAssertio Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Assertio Therapeutics Inc. The current adx is 33.51.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Assertio Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Assertio Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Assertio Therapeutics Inc. The current sar is 1.1814606.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Assertio Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Assertio Therapeutics Inc. The current rsi is 48.15. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Assertio Therapeutics Inc Daily Relative Strength Index (RSI) ChartAssertio Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Assertio Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Assertio Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Assertio Therapeutics Inc Daily Stochastic Oscillator ChartAssertio Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Assertio Therapeutics Inc. The current cci is -21.77057904.

Assertio Therapeutics Inc Daily Commodity Channel Index (CCI) ChartAssertio Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Assertio Therapeutics Inc. The current cmo is -15.81328854.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Assertio Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartAssertio Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Assertio Therapeutics Inc. The current willr is -80.87096774.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Assertio Therapeutics Inc Daily Williams %R ChartAssertio Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Assertio Therapeutics Inc.

Assertio Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Assertio Therapeutics Inc. The current atr is 0.07665888.

Assertio Therapeutics Inc Daily Average True Range (ATR) ChartAssertio Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Assertio Therapeutics Inc. The current obv is -8,793,998.

Assertio Therapeutics Inc Daily On-Balance Volume (OBV) ChartAssertio Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Assertio Therapeutics Inc. The current mfi is 47.79.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Assertio Therapeutics Inc Daily Money Flow Index (MFI) ChartAssertio Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Assertio Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Assertio Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Assertio Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.152
Ma 20Greater thanMa 500.992
Ma 50Greater thanMa 1000.899
Ma 100Greater thanMa 2001.035
OpenGreater thanClose1.010
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Assertio Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Assertio Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Assertio Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Assertio Therapeutics Inc

I send you an email if I find something interesting about Assertio Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Assertio Therapeutics Inc.

Receive notifications about Assertio Therapeutics Inc in your mailbox!